4 Things to Know About Chemotherapy for Peritoneal Mesothelioma

1: Local Chemotherapy Is Common for Peritoneal Patients

You may not know this, but chemotherapy can come in many forms. For peritoneal mesothelioma, the most common types are systemic and local:

• Systemic: Chemotherapy drugs travel throughout the body in the bloodstream.
• Local: Chemotherapy drugs are given only to a specific area of the body, like the abdomen.

Peritoneal tumors develop in areas that don’t get a lot of direct blood flow. So systemic chemo may not reach them. Because of this, doctors often recommend local approaches for patients who can tolerate them. This puts the chemo drugs directly in the area where the tumors grow.

Types of local chemotherapy include HIPEC, NIPEC and PIPAC.

Doctors consider many factors when making mesothelioma treatment recommendations. Some patients may not qualify for local chemo. But if not, systemic approaches are usually still an option. Both approaches can extend survival and may occur alongside surgery.

2: Chemo Is Often Part of a Combination Treatment Plan

Many patients undergo treatment with chemotherapy and surgery. This happens with both systemic and local forms of chemo. Combination treatment is also known as multimodal therapy. Combining different forms of treatment can help boost life expectancy.

Treatment for many peritoneal patients involves surgery followed by systemic or local chemo. In one study, more than 60% of patients received some type of chemotherapy. Nearly 40% of the study patients received surgery and chemo.

Treatment plans vary widely based on many factors. These include age, sex and the mesothelioma cell type. Talk to your doctor about your specific case to see which treatments could be right for you.

3: Survival Varies Based on the Type of Chemo

Peritoneal mesothelioma prognosis can vary quite a bit between patients. These differences are linked to many factors, including treatment plans and health status. And these factors can affect each other. For example, a person in poor health may not be able to withstand surgery. So systemic chemo may be their only option.

In general, plans that include local chemo rather than systemic often lead to a better prognosis. In one study, peritoneal patients treated with systemic chemo had a median survival of about 13 months. For patients treated with surgery and HIPEC, median survivals range from 4 to 8 years.

Again, the type of chemo they receive is only one of many factors that influence patient life expectancy. Talk to a specialist about the best treatment options for your specific case.

4: Chemo Research Is Ongoing

Treatment options for peritoneal mesothelioma have never been better than today. But research is ongoing. Multiple clinical trials are looking into new chemo treatment options.

One trial will compare systemic versus local chemo after surgery. Others are investigating using new drugs and combinations of them. If you’re curious about enrolling in a trial, you can discuss the options with a mesothelioma specialist. Doctors who focus on this rare cancer have the experience and training to help. They can explain which trials or treatments could be the best options for you.